Skip to content
777 Sourcing.

Capability

preclinical drug design and development

Suppliers
1
States & provinces
1
Countries
1

1 preclinical drug design and development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

HELIXOMER, INC.

HILLSBOROUGH,, NC

Helixomer is a preclinical RNA nanodrug company in Research Triangle Park, NC, developing a fully synthetic, reversible anticoagulant to replace heparin and protamine in acute critical care. Its lead program, Hex01 (anticoagulant) and Hex02 (reversal agent), is built on its patented RNA Origami (RNAO) platform and is advancing through IND-enabling studies with Kymanox Venture Studios.

aptamer functionalizationRNA Origami (RNAO) platform

Compiled from public sources

Related capabilities

Other processes offered by the shops that list preclinical drug design and development.

Browse all capabilities